Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs

Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia

(2018) Simson Tarigan et al.   PLoS One

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

(2018) Young-Tae Lee et al.   PLoS One

Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection

(2018) Su-Hwa Lee et al.   VACCINE

Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection

(2017) Su-Hwa Lee et al.   PLoS One

A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus

(2016) Yu-Na Lee et al.   JOURNAL OF IMMUNOLOGY

Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses

(2016) Darrell R. Kapczynski et al.   VACCINE

Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens

(2016) Byung-Min Song et al.   VACCINE

Protection induced by early stage vaccination with pandemic influenza virus-like particles

(2016) Gi-Ja Lee et al.   VACCINE

Avian influenza vaccination: the experience in China

(2016) H. CHEN   REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES

Early Growth Response-1 Plays a Non-redundant Role in the Differentiation of B Cells into Plasma Cells

(2015) Yeon-Kyung Oh et al.   Immune Network

Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection

(2014) Min-Chul Kim et al.   MOLECULAR THERAPY

Enhanced protection againstClonorchis sinensisinduced by co-infection withTrichinella spiralisin rats

(2014) K.-B. Chu et al.   PARASITE IMMUNOLOGY

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity

(2014) Min-Chul Kim et al.   VACCINE

Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection

(2013) Min-Chul Kim et al.   ANTIVIRAL RESEARCH

Protective CD8 T Cell-Mediated Immunity against Influenza A Virus Infection following Influenza Virus-like Particle Vaccination

(2013) E. A. Hemann et al.   JOURNAL OF IMMUNOLOGY

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

(2012) Min-Chul Kim et al.   MOLECULAR THERAPY

Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice

(2011) Fu-Shi Quan et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity

(2011) Jae-Min Song et al.   PLoS One

Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection againstHelicobacter pyloriInfection in Mice: an Important Role for Interleukin-17 during the Effector Phase

(2010) Carl-Fredrik Flach et al.   INFECTION AND IMMUNITY

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice

(2010) Fu-Shi Quan et al.   PLoS One

Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles

(2010) Jae-Min Song et al.   VIROLOGY

Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses

(2008) B.-Z. Wang et al.   JOURNAL OF VIROLOGY

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

(2008) Benoît Baras et al.   PLoS One